Eledon Pharmaceuticals
ELDN
ELDN
28 hedge funds and large institutions have $12.2M invested in Eledon Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 8 increasing their positions, 9 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less ownership
Funds ownership: →
63% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 8
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $6K
Holders
28
Holding in Top 10
–
Calls
–
Puts
$6K
Top Buyers
| 1 | +$120K | |
| 2 | +$23.8K | |
| 3 | +$17.9K | |
| 4 |
CRC
Curi RMB Capital
Chicago,
Illinois
|
+$13.7K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$8.76K |
Top Sellers
| 1 | -$304K | |
| 2 | -$158K | |
| 3 | -$30.2K | |
| 4 |
JE
JMAC Enterprises
Newtown,
Pennsylvania
|
-$30.1K |
| 5 |
AC
Armistice Capital
New York
|
-$25.8K |